[HTML][HTML] Left ventricular systolic function in HER2/neu negative breast cancer patients treated with anthracycline chemotherapy: a comparative analysis of left …
PW Stoodley, DAB Richards, A Boyd, R Hui… - European journal of …, 2013 - Elsevier
Aim Anthracycline agents are undermined by their cardiotoxicity. As life expectancy
following treatment is greatly improved, techniques that ensure early detection and timely
management of cardiotoxicity are essential. The aim of the present study was to evaluate left
ventricular (LV) systolic function with LV ejection fraction (LVEF) and two-dimensional
myocardial strain up to 12 months after anthracycline chemotherapy, specifically in
HER2/neu negative breast cancer patients. Methods Seventy-eight consecutive …
following treatment is greatly improved, techniques that ensure early detection and timely
management of cardiotoxicity are essential. The aim of the present study was to evaluate left
ventricular (LV) systolic function with LV ejection fraction (LVEF) and two-dimensional
myocardial strain up to 12 months after anthracycline chemotherapy, specifically in
HER2/neu negative breast cancer patients. Methods Seventy-eight consecutive …
以上显示的是最相近的搜索结果。 查看全部搜索结果